Mendelspod Podcast

26:22

February 2016: Mosquitos, Preprints, and that Rocking...

Mendelspod Podcast ·

2016/03/01

It’s time again to look back on another month with Nathan and Laura. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

32:25

BioNano Genomics Stakes Out Sequencing Territory as...

Mendelspod Podcast ·

2016/02/25

If you attended or followed the recent AGBT conference about all things sequencing, you probably saw a few BioNano Genomics t-shirts with the slogan, “Back to the Map.” They’re referring of course, to a genome map. Just like Google Maps, a genome map consists of landmarks that tell scientists where on the genome they are. But unlike Google Maps and more like the maps North America that were made by European explorers in the 17th century, the map of the human genome is quite incomplete, the map of

en

25:42

Is Oxitec Ready to Scale as Governments Seek Options...

Mendelspod Podcast ·

2016/02/23

With constant news topping the headlines about the Zika virus, a synthetic biology company out of Oxford England, Oxitec, has been getting some good press. For over ten years now, Oxitec has been developing their genetically engineered mosquitos as a way to lower virus spreading mosquito populations. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

27:10

Human Genome Turns 15: Mike Hunkapiller

Mendelspod Podcast ·

2016/02/04

We’re all familiar with the announcement in the year 2000 by US President, Bill Clinton, and the UK’s Prime Minister, Tony Blair, that scientists had completed the first draft of the human genome. It was a big deal. But the actual publications didn’t happen until the next year, February of 2001. Which means that this February is the fifteenth anniversary of the publication of the first human genome. For our commemorative show we’re joined by Mike Hunkapiller, the CEO of Pacific Biosciences. This

en

20:14

January 2016: Landergate, Grail, and Cancer Moonshot

Mendelspod Podcast ·

2016/02/01

“It being the month of Hypeuary, go hither through break in yonder wall called LanderGate, and thou wilt be on route to reach the Grail. Drink from this to find your Cure, and Death shall haunt you even more.” -Pithy Monton This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

32:01

Frontiers of Sequencing: Putting Long Reads and Graph...

Mendelspod Podcast ·

2016/01/28

OK, so we get it. Long read sequencing technology is cool. But how cool? Is it another great player on the field, or does it change the game altogether? This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

26:55

Why Drugs Are Priced So High and Diagnostics So Low

Mendelspod Podcast ·

2016/01/21

Pharma companies face escalated flack over high drug prices. Meanwhile the diagnostics industry toils away at comparative pennies to the dollar. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

31:19

Who Is John Ioannidis?

Mendelspod Podcast ·

2016/01/14

It’s now been over ten years since John Ioannidis published his now famous paper, Why Most Published Research Findings Are False. What response has John seen from the scientific community? How has the paper changed his career and role in the scientific community? Join us for a look at science itself. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

35:27

Cancer: Year in Review 2015 with Anna Barker

Mendelspod Podcast ·

2015/12/30

As we begin the countdown to the new year, we take a look back at 2015 in cancer research, treatment and prevention. Mendelspod is increasingly becoming known for the coverage of genomics and precision medicine, and cancer as a disease area offers a specific window whereby we can look at practical outcomes. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

36:43

Sci-Fi Author Kim Stanley Robinson Talks Life Science...

Mendelspod Podcast ·

2015/12/22

At the end of the year our goal is to bring the audience some unusual programming, some new outside perspectives on the topics we cover. As with last year, we talk today with science fiction writer, Kim Stanley Robinson, author of the Mars Trilogy, 2312, and Shaman. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

28:48

Yes to FDA Regulation of LDTs, But We Need a New...

Mendelspod Podcast ·

2015/12/03

We set up an interview with David Spetzler, the CSO of Caris Life Sciences, to hear about some promising new liquid biopsy tests they are developing. And we do that in today’s show. But first, the interview takes a turn toward the regulation of molecular tests. Spetzler says that Caris is already doing as many quality certifications as possible short of FDA oversight. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit

en

28:13

Genomics and the Cloud Going Through “a Second...

Mendelspod Podcast ·

2015/11/24

Angel Pizarro has watched as genomics and cloud computing have grown up together. Formerly a bioinformatics director at University of Pennsylvania, Angel is now the Technical Business Development Manager at Amazon Web Services.At U Penn, Angel was part of the shift from setting up one’s own facility with expensive computer equipment for handling the rapid growth of omics data to using a third party service, such as AWS. He says that genomics and the cloud are both going through a "second

en

23:16

Hot Biotech Market Neglects Stem Cell Therapies, Says...

Mendelspod Podcast ·

2015/11/18

In 2004, California voters approved Prop 71 to fund the field of stem cell research by setting up the California Institute of Regenerative Medicine, or CIRM, with $3 billion. George W. Bush was in the White House at the time, and since 2001, his administration had been limiting research that used embryonic stem cells. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

23:16

The Future of Diagnostics Reimbursement with Bruce Quinn

Mendelspod Podcast ·

2015/11/12

We toss the term "precision medicine" around with ease today, and yet payers continue to refuse to pay for diagnostic tests.These are tests that might indicate which treatment will work for a specific patient, thereby saving perhaps hundreds of thousands of dollars, not to mention protecting the patient from unnecessary harm. These are tests which prevent invasive procedures such as unnecessary biopsies. This is a public episode. If you'd like to discuss this with other subscribers or get access to

en

19:23

Framingham for the Modern Era: Josie Briggs on the...

Mendelspod Podcast ·

2015/11/04

Josie Briggs is Director of the National Center for Complementary and Integrative Health (NCCIH) at the NIH. She is also currently serving as interim director of the president’s new Precision Medicine Initiative (PMI).What has happened since the president announced the initiative, what is the proposed timeline going forward, and how much money will there be for the project ongoing? This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit

en

24:05

Do Alternate Proposals to Regulate LDTs Stand a Chance?

Mendelspod Podcast ·

2015/10/29

As the FDA works away on final guidance for regulating LDTs, various professional groups unhappy with the course of the FDA have put together and hurried their own proposals up to Captiol Hill. The Diagnostic Testing Working Group (DTWG) has had their proposal drafted into legislation which has already been revised once in the House Energy and Commerce Committeee, while proposals from the College of American Pathologists (CAP) and the Association of Molecular Pathology (AMP) have been presented to

en

23:47

Does the Reproducibility Project in Cancer Biology...

Mendelspod Podcast ·

2015/10/27

Here on the show, we’ve talked about the lack of reproducibility for much of biological research. We’ve bandied around various percentages--is it 50% or up to 90% that can't be replicated? And we’ve poked around various issues that may be causing such poor science.Nicole Perfito is the manager of the Reproducibility Project: Cancer Biology, an effort between Science Exchange and the Center for Open Science. The goal of this project is to take nearly forty “high impact” papers in the field of

en

19:20

After CMS Announcement, Peter Maag and CareDx Fight...

Mendelspod Podcast ·

2015/10/22

By listening to him, you wouldn’t know that Peter Maag, the CEO of CareDx, was fighting to keep his company from the brink. We booked Peter for the show after news came out that CMS was once again threatening to lower reimbursement rates of established diagnostic tests. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.mendelspod.com/subscribe

en

23:01

The Goal Is De Novo Assembly in the Clinic, Says Jim...

Mendelspod Podcast ·

2015/10/20

Today’s story is one of a personal quest, of groundbreaking science, and the creation of a new movement in human genomics.Jim Lupski is a professor at Baylor College of Medicine where he’s on the frontline of incorporating genomic research into everyday clinical practice. The story begins with Jim’s own genome, which is perhaps the most sequenced genome ever. Jim's life as a leading genomic researcher has been driven in part for a strong personal reason. He has a rare genetic disease named after

en

28:37

Cliff Reid Says New Supersequencer Leads the Pack for...

Mendelspod Podcast ·

2015/10/16

Cliff Reid, CEO of Complete Genomics, is back on the conference circuit, touting a new product. After years of building his company to do sequencing as a service, Cliff presented data at last week's ASHG meeting on Complete's first sequencer as a product, or what they are calling the Revolocity supersequencer.Cliff was a pioneer in developing the service model, offering only whole human genome sequencing. But after being bought out by BGI, who already had a service business in China, he was

en

All Episodes

Similar Podcasts

天方烨谈

基因频道

Mendelspod Podcast

Theral Timpson

DMCN Journal

John Wiley & Sons Ltd

汪诘：科学有故事（主打）

科学有故事

Homesteading and Permaculture by Paul Wheaton

paul wheaton